23 Animal studies have demonstrated neuroprotective effects associated with GLP-1RA use in Alzheimer and Parkinson disease, stroke, and ocular hypertension
Shared decision-making between patients and clinicians should weigh cardiovascular benefits against cost, adverse effects, and individual treatment goals
When to Speak with Your GP About GLP-1 You should arrange an appointment with your GP if you are experiencing persistent symptoms that may indicate metabolic dysfunction, regardless of whether they relate specifically to GLP-1
Whether you achieve a 20% weight reduction through bariatric surgery, strict dieting, or an AOM, the composition of that weight loss remains remarkably consistent
While not yet approved, its development represents a major step forward in oral weight management treatments
Although previous studies showed a lack of therapeutic benefit for GIP agonists, current studies show that the glucose lowering and weight loss effects of tirzepatide are at least as effective as GLP-1 RAs with a similar adverse effect profile